1. Market Research
  2. > Chronic Disease Industry

Heart Failure Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Cardiovascular Disease, Cardiac Management, Therapy, Biomarker, Cardiac Monitoring, Hemodynamic Monitor, Point Of Care Testing, Prosthesis, Cardiology, Cardiovascular Drug, Diagnostics, Hypertension, Stem Cell, Surgery, Healthcare, Insulin, Medical Device, Musculoskeletal Disorder, Neurological Disorder, Pharmaceutical.


 
1-10 of 49 reports for Heart Failure

Purchase Reports From Reputable Market Research Publishers

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 754
  • Industry report
  • Sep 2016
  • by Firstword Pharma

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. ...

Global Congestive Heart Failure Partnering 2010 to 2016

Global Congestive Heart Failure Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed ...

Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Chronic Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

 Chronic Heart Failure-Pipeline Insights, 2016

Chronic Heart Failure-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Chronic Heart Failure-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Heart Failure. ...

 Acute Heart Failure-Pipeline Insights, 2016

Acute Heart Failure-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Acute Heart Failure-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Acute Heart Failure. The ...

Acute Heart Failure Global Clinical Trials Review, H2, 2016

Acute Heart Failure Global Clinical Trials Review, H2, 2016

  • $ 2 500
  • Industry report
  • July 2016
  • by Global Data

Acute Heart Failure Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2016" provides an overview of Acute Heart ...

Acute Heart Failure - Pipeline Review, H2 2016

Acute Heart Failure - Pipeline Review, H2 2016

  • $ 2 000
  • Company report
  • July 2016
  • by Global Markets Direct

Acute Heart Failure - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2016’, provides an overview of the Acute Heart Failure pipeline landscape. ...

PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025

  • $ 10 995
  • Industry report
  • May 2016
  • by Global Data

PharmaPoint: Heart Failure - Global Drug Forecast and Market Analysis to 2025 Summary GlobalData estimates sales of Heart Failure (HF) therapeutics to be approximately $3.2B across the 7MM in 2015, encompassing ...

About 9 200 reports for Heart Failure

Download Unlimited Documents from Trusted Public Sources

Heart Failure Statistics in the US

  • January 2015
    84 pages
  • Heart Failure  

    Cardiovascular ...  

    Therapy  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.